| This week's sponsor is Premier Research. | |  | Immunotherapy: Unleashing the Body's Potential to Fight Cancer
The immune system's role in fighting cancer becomes clearer every day, and the therapeutic implications are enormous. Discover promising new approaches to immunotherapy in our new white paper.
Premier Research. It's what we do. Best. |
Featured Story | | | Thursday, June 22, 2017 Biotech stocks have had their most buoyant patch in months, with three straight days of solid gains on reports that President Donald Trump's threatened crackdown on pricing may not be as tough as feared. |
|
|
| This week's sponsor is Myriad RBM. | |  | |
Top Stories Thursday, June 22, 2017 After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an impressive $68 million. Thursday, June 22, 2017 Eli Lilly has completed the expansion of its biotech facility in San Diego, California. The Big Pharma has more than doubled the size of the West Coast site and installed an automated, remote-controlled drug design and testing studio. Monday, June 19, 2017 How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development Thursday, June 22, 2017 ElexoPharm has licensed inhibitors of the aldosterone synthase enzyme to Angion Biomedica. The exclusive pact comes seven years after ElexoPharm struck a deal granting Merck rights to drugs against the same target. Wednesday, June 21, 2017 Walgreens, an early partner and validator for Theranos, sued the latter last fall for breach of contract and sought $140 million in damages. Now, sources say, the pair have reached a tentative agreement to put the suit to rest. Wednesday, June 21, 2017 Clinigen has signed exclusive agreements with Mitsubishi Tanabe, Shionogi and Romark to cooperate on expanded access to their medicines. Thursday, June 22, 2017 Most treatments for blood cancers like acute myeloid leukemia (AML) are designed to attack the cancer cells themselves. Now, scientists at Pfizer have figured out how to make those cells even more vulnerable to direct attack—by driving them from their favorite hiding place. Thursday, June 22, 2017 Russia has long been considered a prime market for Western biopharma companies, and companies ranging from Pfizer to AstraZeneca have been clamoring to comply with President Vladimir Putin’s demand that they ally with local producers and establish manufacturing plants in Russia. But now Russia is pushing back on an issue that has raised concerns around the world: cancer drug prices. | This week's sponsor is J.P. Morgan Private Bank. | |  | How Your Assets Are Structured Can Have Long-Term Implications On Your Wealth
As a founder or executive of a healthcare business, it's crucial your assets are titled properly. J.P. Morgan Private Bank knows how to protect your assets and preserve your wealth. Download this article on asset ownership to learn more. |
| | | Chi-Med said it has just started a phase 1/2 test of HMPL-453 in China that is targeting fibroblast growth factor receptors. Statement After Seattle Genetics stopped all trials of its blood cancer drug following patient deaths this week, it said in a SEC form that the FDA has now also slapped a formal clinical hold on its IND. SEC form Bristol-Myers Squibb veteran Elyse Stock, M.D., has been appointed as Biohaven's new chief of portfolio strategy and development. Release | |
|
Resources Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Envigo Discover the factors that contribute to differential radiation sensitivity between the Rag2 and SCID models. Presented by: Veeva Hear three innovative leaders explain how regulatory can “go digital” in their operations by leveraging the data-handling capabilities in their RIM systems. Sponsored by Envigo Performing a sophisticated surgery to create a myocardial infarction model. Join us on June 7th at 11:00 AM EDT. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. |
|
